Recombinant SARS-CoV-2 Spike (Casirivimab Biosimilar) anticorps

N° du produit ABIN7795137

L’anticorps anti-SARS-CoV-2 Spike (Casirivimab Biosimilar) Monoclonal Human est utilisé pour la détection de SARS-CoV-2 Spike (Casirivimab Biosimilar) dans des échantillons de Humain. Il a été validé pour FACS et in vivo.

Aperçu rapide pour Recombinant SARS-CoV-2 Spike (Casirivimab Biosimilar) anticorps (ABIN7795137)

Antigène: SARS-CoV-2 Spike (Casirivimab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit

Expression System: Mammalian cells

Fonction: Casirivimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody

Attributs du produit: What is casirivimab biosimilar research grade? Casirivimab is a human monoclonal antibody directed against the spike protein of SARS-CoV-2. Casirivimab is a human monoclonal antibody (IgG1κ isotype). Casirivimab biosimilar uses the same protein sequences as the therapeutic antibody casirivimab. Casirivimab/imdevimab is a combination medicine used for the treatment and prevention of COVID-19. It consists of two human monoclonal antibodies, casirivimab and imdevimab that must be mixed together and administered as an infusion or subcutaneous injection. The combination of two antibodies is intended to prevent mutational escape. Casirivimab and imdevimab bind distinct epitopes on the RBD with dissociation constants KD of 46 and 47 pM, respectively. Please contact us if you are interested in the anti-SARS-CoV-2 spike monoclonal antibody imdevimab biosimilar.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détail du antigène

Antigène: SARS-CoV-2 Spike (Casirivimab Biosimilar)

Autre désignation: Casirivimab Biosimilar

Classe de substances: Biosimilar